AGM/EGMSep 18, 2026, 07:19 AM
Roivant Sciences Ltd. Shareholders Re-elect Directors, Ratify Auditor Appointment
AI Summary
Roivant Sciences Ltd. held its 2026 Annual General Meeting of Shareholders on September 16, 2026. Shareholders re-elected two Class II directors, ratified the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending March 31, 2027, and approved, on a non-binding advisory basis, the compensation of the Company's named executive officers. A quorum of approximately 90.3% of outstanding shares was present.
Key Highlights
- Shareholders re-elected Daniel Gold and Meghan FitzGerald as Class II directors.
- Ernst & Young LLP ratified as independent registered public accounting firm for FY ending March 31, 2027.
- Shareholders approved, on a non-binding advisory basis, the compensation of named executive officers.
- Approximately 90.3% of outstanding shares were present at the meeting, constituting a quorum.
Price Impact
More from ROIV
More in AGM/EGM